The FDA added the postmarketing reports of ileus, or blocked intestines, to the drug labeling for semaglutide (Ozempic). "Because these reactions are reported voluntarily from a population of ...

The FDA is updating Ozempic's warning label to acknowledge reports of bowel obstruction Mario Tama/Getty Images The FDA has issued another update to the warning label for Ozempic, saying it has ...

The U.S. Food and Drug Administration has updated the Ozempic label to acknowledge complaints of blocked intestines in some people who have taken the medication. The semaglutide drug is designed for ...

The U.S. Food and Drug Administration has updated the label for Ozempic to include intestinal blockage, or ileus, as a side effect after reports from some users. “Because these reactions are reported ...

The label for Novo Nordisk’s weight loss drug Ozempic now acknowledges some users’ reports of ileus, or intestinal blockage. In its update, however, the FDA said it’s difficult to confirm a causal ...

While GLP-1 drugs from Novo Nordisk and Eli Lilly are believed to be relatively free of serious side effects, a few problems have emerged as the treatments have gained wider and longer-term use. One ...

The buzzy injectable drug for type 2 diabetics, Ozempic, has become a household name in 2023 thanks to reports that the medication can be prescribed off-label and used for significant weight loss.

On September 22, the U.S. Food and Drug Administration added ileus—which can result in intestinal blockage—as a possible adverse event to the Ozempic label. (Photo by Jaap Arriens/NurPhoto via Getty ...

The FDA stopped short, however, of saying that semaglutide, the active ingredient in Ozempic — as well as Wegovy, its counterpart prescribed for weight loss — was the cause of the condition. “Because ...